[CAS NO. 386750-22-7]  Desvenlafaxine Succinate hydrate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [386750-22-7]

Store
Catalog
SLK-S4112
Brand
Selleck
CAS
386750-22-7

DESCRIPTION [386750-22-7]

Overview

MDL-
Molecular Weight399.48
Molecular FormulaC16H25NO2.C4H6O4.H2O
SMILESCN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5033 mL12.5163 mL25.0325 mL
5 mM0.5007 mL2.5033 mL5.0065 mL
10 mM0.2503 mL1.2516 mL2.5033 mL
50 mM0.0501 mL0.2503 mL0.5007 mL

Description

Desvenlafaxine Succinate hydrate (WY 45233) is a new transporter and transporter reuptake inhibitor with of 40.2 nM and 558.4 nM respectively.

Features

A major active metabolite of venlafaxine.

Targets

5-HT [1]Norepinephrine (NE) [1]
40.2 nM(Ki)558.4 nM(Ki)

In vitro

Desvenlafaxine succinate is the succinate salt monohydrate of O-desmethylvenlafaxine, an active metabolite of venlafaxine. Desvenlafaxine Succinate is a serotonin-norepinephrine reuptake inhibitor and is the active metabolite of the antidepressant venlafaxine. Similar to venlafaxine, Desvenlafaxine Succinate inhibits the neuronal uptake of serotonin and norepinephrine. Desvenlafaxine Succinate shows weak binding affinity (62% inhibition at 100 μM) at the human dopamine (DA) transporter. Desvenlafaxine Succinate inhibits [H]5-HT or [H]NE uptake for the hSERT or hNET with IC50 of 47.3 and 531.3 nM, respectively. Desvenlafaxine Succinate has the potential to inhibit CYP2D6, which could result in increased concentrations of drugs metabolized through this pathway. Induction of CYP3A4 is also possible with Desvenlafaxine Succinate, which could impact the metabolism of drugs metabolized via this enzyme.